Cowin Capital
China industrial supplies platform ZKH pursues US IPO
ZKH Group, a China-based industrial supplies platform backed by the likes of Eastern Bell Capital, Genesis Capital, Tencent Holdings, and Tiger Global Management, has filed to list in the US.
Capcon Semiconductor raises $50m
Hillhouse Capital, Cowin Capital, Chengchuang Capital, and SAIC Motor Corporation's Shangqi Capital have participated in a USD 50m extended Series B round for Capcon, a Chinese-founded supplier of semiconductor assembly and packaging equipment.
Med-Fine leads Series A for China's Degron Therapeutics
US and China-based biotech player Degron Therapeutics has closed a USD 22m Series A round led by Med-Fine Capital.
China machine vision company AlpsenTek raises $30m
Chinese machine vision developer AlpsenTek has raised a CNY 200m (USD 30m) Series A round led by Xunxing Investment, an arm of mobile brand Oppo, and Cowin Capital.
Goldman, Sofina lead Series C for China CDMO Zhenge
Goldman Sachs Asset Management and Sofina have led a USD 100m Series C round for Zhenge Biotech, a Shanghai-based contract development and manufacturing organisation (CDMO).
China's Connect Biopharma gains 8% on debut after $191m US IPO
Connect Biopharma, a China-headquartered drug developer specializing in treatments for T cell-driven inflammatory diseases, gained 8.8% on debut following a $191.3 million US IPO.
YF Capital leads $315m Series E for China MRO player
Zhenkunhang, a China-based distribution platform for industrial products, has raised $315 million Series E funding led by YF Capital - previously Yunfeng Capital - a private equity firm co-founded by Alibaba’s Jack Ma.
Chinese mouse-based drug testing specialist raises $143m
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.
Chinese instant food brand Baijia raises $28m
Chinese instant food brand Baijia Food has raised RMB200 million ($28 million) in Series B funding led by GL Ventures, the venture capital arm of Hillhouse Capital.
China's Haier raises $134m for industrial internet platform
COSMOPlat, an industrial internet platform developed by Chinese home appliance giant Haier Group, has raised RMB950 million ($134 million) in Series A funding led by the state-owned China Structural Reform Fund.
Shanghai CDMO player gets $51m Series A
Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $51 million in Series A funding led by Lyfe Capital.
Chinese healthcare software provider raises $212m
Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs) has raised RMB1.5 billion ($212 million) through an extended Series E round of funding.
Advantech leads $55m round for China biotech player
Advantech Capital has led a $55 million Series B funding round for China’s Connect Biopharmaceuticals with support from Qiming Venture Partners.
Legend, Tiger back Chinese industrial e-commerce platform
Legend Capital and Tiger Global Management have led a $129 million Series C round for Zhenkunhang, a Chinese e-commerce platform that specializes in industrial products.
Cancer drug developer Innovent Biologics files for HK IPO
Innovent Biologics, a Chinese drug developer company with a number of PE backers, has filed for an IPO in Hong Kong under recently introduced rules allowing listings by biotech companies with no revenue or profits.
Chinese healthcare SaaS platform raises $48m
Taimei Medical Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs), has raised RMB300 million ($48 million) in Series D funding.
GPs on China's New Third Board: Public market oddity
A dozen Chinese private equity firms have been listed on the New Third Board in recent years, but the model is far removed from that seen in other markets and regulators are concerned
China's Cowin Capital to exit jewelry retailer Myray
Shenzhen Cowin Capital is poised to exit jewelry retailer Myray to Gansu Gangtai Holdings following the Shanghai-listed company's agreement to buy a further 36.96% of Myray for RMB170 million ($26 million).
Google, Lightspeed-backed InnoLight files for US IPO
InnoLight Technology, a manufacturer of components used in cloud computing and Google Capital’s first China-based portfolio company, has filed for an IPO in the US.
China GPs wary of public market volatility, regulation - AVCJ Forum
China’s A-share market may be trading record highs, but PE investors told the AVCJ China forum that they are still wary of public market exits, citing the amount of time it takes to complete the process.
China’s Huakang Mobile Healthcare raises $32m from VCs
Yunfeng Capital, Shenzhen Cowin Capital, New Horizon Capital and Hunan Haijie Healthcare Investment have provided RMB200 million ($32 million) in Series B funding for Huakang Mobile Healthcare, a Chinese mobile healthcare app developer.
China sex toy online retailer Chunshuitang raises $13m
New Margin Ventures and Shenzhen Cowin Capital have committed RMB80 million ($13 million) in a Series B round of funding for Chunshuitang.com, a Chinese sex toy e-commerce site.
Chinese playground operator Yuyuto raises $32m
Shanghai Yuyuto Entertainment Facilities, a Chinese company that operates children’s entertainment and retail facilities in shopping malls, has secured RMB200 million ($32 million) in a new round of funding from Fortune Venture Capital, Shenzhen Cowin...
Cowin Capital exits China department store via trade sale
Shenzhen Cowin Capital is set to make a full exit from Guangxi Nancheng Department Store as Better Life Commercial Chain Share won approval to buy its rival.